End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,720 KRW | 0.00% |
|
-11.00% | -29.55% |
2023 | U2Bio Co., Ltd. has filed an IPO. | CI |
2020 | Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. | CI |
1 week | -11.00% | ||
Current month | -17.33% | ||
1 month | -10.79% | ||
3 months | -14.68% | ||
6 months | -29.68% | ||
Current year | -29.55% |
![Extreme 3690](/images/extremecours_fleche.png)
![Extreme 3690](/images/extremecours_fleche.png)
![Extreme 3690](/images/extremecours_fleche.png)
![Extreme 3690](/images/extremecours_fleche.png)
![Extreme 2800](/images/extremecours_fleche.png)
![Extreme 1810](/images/extremecours_fleche.png)
![Extreme 1810](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Jin-Tae Kim
CEO | Chief Executive Officer | 60 | 31/10/09 |
Ji-Won Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/12/10 |
Hyuk-Sung Jin
BRD | Director/Board Member | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jang-Ho Park
BRD | Director/Board Member | 53 | - |
Jin-Tae Kim
CEO | Chief Executive Officer | 60 | 31/10/09 |
Ji-Won Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/12/10 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.55% | 30.21M | |
-22.28% | 77.04B | |
+3.24% | 26.87B | |
-9.70% | 17.3B | |
0.00% | 16.89B | |
+0.78% | 15.44B | |
-23.68% | 13.16B | |
+70.99% | 13.15B | |
+77.65% | 13.11B | |
+24.05% | 12.66B |
- Stock Market
- Equities
- A221800 Stock